{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:52:24Z","timestamp":1648997544401},"reference-count":13,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.arbres.2018.03.012","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T13:28:57Z","timestamp":1527168537000},"page":"637-638","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mesotelioma pleural maligno: experiencia de los \u00faltimos 8 a\u00f1os en nuestra \u00e1rea"],"prefix":"10.1016","volume":"54","author":[{"given":"Jos\u00e9 Carlos","family":"Ben\u00edtez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Campayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Call","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rom\u00e0","family":"Bast\u00fas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2018.03.012_bib0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.arbres.2014.06.005","article-title":"Diagn\u00f3stico y tratamiento del mesotelioma pleural maligno","volume":"51","author":"Rodr\u00edguez Panadero","year":"2015","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2018.03.012_bib0075","author":"Aisner","year":"2017","journal-title":"NCCN Guidelines Version 2.2017 Panel Members Malignant Pleural Mesothelioma NCCN Guidelines Panel Disclosures-Farber\/Brigham and Women's Cancer Center"},{"key":"10.1016\/j.arbres.2018.03.012_bib0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/17476348.2018.1398085","article-title":"Surgical and non-surgical management of malignant pleural effusions","volume":"12","author":"Fitzgerald","year":"2018","journal-title":"Expert Rev Respir Med."},{"key":"10.1016\/j.arbres.2018.03.012_bib0085","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(08)60727-8","article-title":"Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial","volume":"371","author":"Muers","year":"2008","journal-title":"Lancet."},{"key":"10.1016\/j.arbres.2018.03.012_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lungcan.2014.01.021","article-title":"Surgery for malignant pleural mesothelioma: Why, when and what?","volume":"84","author":"Lang-Lazdunski","year":"2014","journal-title":"Lung Cancer."},{"key":"10.1016\/j.arbres.2018.03.012_bib0095","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: Clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.arbres.2018.03.012_bib0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/17476348.2016.1171147","article-title":"The role of thoracic surgery in the management of mesothelioma: an expert opinion on the limited evidence","volume":"10","author":"Bertoglio","year":"2016","journal-title":"Expert Rev Respir Med."},{"key":"10.1016\/j.arbres.2018.03.012_bib0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.lungcan.2016.07.023","article-title":"How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?","volume":"100","author":"Sharkey","year":"2016","journal-title":"Lung Cancer."},{"key":"10.1016\/j.arbres.2018.03.012_bib0140","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"3","author":"Van Meerbeeck","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.arbres.2018.03.012_bib0135","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesotehelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.arbres.2018.03.012_bib0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.lungcan.2014.03.006","article-title":"Vinorelbina and gemcitabine as second \u2014 or third-line therapy for malignant pleural mesothelioma","volume":"84","author":"Zauderer","year":"2014","journal-title":"Lung Cancer."},{"key":"10.1016\/j.arbres.2018.03.012_bib0125","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2017.72.9012","article-title":"Nintedanib plus pemetrexed\/cisplatin in patients with malignant pleural mesothelioma: Phase II results from the randomized, placebo-controlled LUME-meso trial","volume":"35","author":"Grosso","year":"2017","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.arbres.2018.03.012_bib0130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","article-title":"Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): Preliminary results from a non-randomised, open-label, phase 1b trial","volume":"18","author":"Alley","year":"2017","journal-title":"Lancet Oncol."}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289618301613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289618301613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T12:40:13Z","timestamp":1543668013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289618301613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0300289618301613"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2018.03.012","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesotelioma pleural maligno: experiencia de los \u00faltimos 8 a\u00f1os en nuestra \u00e1rea","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2018.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}